Report Summary

The global Rett Syndrome market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 10.10% during the forecast period

The rett syndrome market is expected to gain market growth in the forecast period of 2019 to 2028. Rett syndrome is a rare genetic neurological disorder that is more common among girls and leads to severe impairment affecting their ability to speak, walk and eat. Rett syndrome is recognized in child between 6-18 months caused by mutations on the X-chromosome over a gene called MECP2. Rett syndrome can cause wide range of disabilities from mild to severe



Market Drivers

The rise in female population, expenditure on public healthcare programs and rising healthcare spending, availability of development of new drugs and use of advanced technologies drives the global rett syndrome market growth. However, increased focus on gene therapy treatment worldwide also boost up the global rett syndrome market. But, the high cost of treatment and rising R&D expenditure for the treatment of rett syndrome may hamper the rett syndrome market